Evolving Switch Scene Could Drive Nonprescription Reimbursement – Gottlieb
This article was originally published in The Tan Sheet
Executive Summary
Drug sponsors should work with insurers in advance of nonprescription switches to develop reimbursement plans to benefit consumers, particularly when considering a behind-the-counter switch, former FDA Deputy Commissioner Scott Gottlieb advises